Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy.
Di Rocco A, Cuneo A, Di Rocco A, Merli F, De Luca G, Petrucci L, Ansuinelli M, Penna D, Rotondo F, Rigolin GM, Giaimo M, Re F, Farcomeni A, Martelli M, Foà R.
Di Rocco A, et al. Among authors: cuneo a.
Leuk Lymphoma. 2021 Apr;62(4):828-836. doi: 10.1080/10428194.2020.1849676. Epub 2020 Dec 4.
Leuk Lymphoma. 2021.
PMID: 33274677